Cargando…
Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation
Growing interest in the development of innovative functional products as ideal carriers for synbiotics, e.g., nutrient bars, yogurt, chocolate, juice, ice cream, and cheese, to ensure the daily intake of probiotics and prebiotics, which are needed to maintain a healthy gut microbiota and overall wel...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230215/ https://www.ncbi.nlm.nih.gov/pubmed/34200108 http://dx.doi.org/10.3390/foods10061297 |
_version_ | 1783713155804823552 |
---|---|
author | Kvakova, Monika Bertkova, Izabela Stofilova, Jana Savidge, Tor C. |
author_facet | Kvakova, Monika Bertkova, Izabela Stofilova, Jana Savidge, Tor C. |
author_sort | Kvakova, Monika |
collection | PubMed |
description | Growing interest in the development of innovative functional products as ideal carriers for synbiotics, e.g., nutrient bars, yogurt, chocolate, juice, ice cream, and cheese, to ensure the daily intake of probiotics and prebiotics, which are needed to maintain a healthy gut microbiota and overall well-being, is undeniable and inevitable. This review focuses on the modern approaches that are currently being developed to modulate the gut microbiota, with an emphasis on the health benefits mediated by co-encapsulated synbiotics and immobilized probiotics. The impact of processing, storage, and simulated gastrointestinal conditions on the viability and bioactivity of probiotics together with prebiotics such as omega-3 polyunsaturated fatty acids, phytochemicals, and dietary fibers using various delivery systems are considered. Despite the proven biological properties of synbiotics, research in this area needs to be focused on the proper selection of probiotic strains, their prebiotic counterparts, and delivery systems to avoid suppression of their synergistic or complementary effect on human health. Future directions should lead to the development of functional food products containing stable synbiotics tailored for different age groups or specifically designed to fulfill the needs of adjuvant therapy. |
format | Online Article Text |
id | pubmed-8230215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82302152021-06-26 Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation Kvakova, Monika Bertkova, Izabela Stofilova, Jana Savidge, Tor C. Foods Review Growing interest in the development of innovative functional products as ideal carriers for synbiotics, e.g., nutrient bars, yogurt, chocolate, juice, ice cream, and cheese, to ensure the daily intake of probiotics and prebiotics, which are needed to maintain a healthy gut microbiota and overall well-being, is undeniable and inevitable. This review focuses on the modern approaches that are currently being developed to modulate the gut microbiota, with an emphasis on the health benefits mediated by co-encapsulated synbiotics and immobilized probiotics. The impact of processing, storage, and simulated gastrointestinal conditions on the viability and bioactivity of probiotics together with prebiotics such as omega-3 polyunsaturated fatty acids, phytochemicals, and dietary fibers using various delivery systems are considered. Despite the proven biological properties of synbiotics, research in this area needs to be focused on the proper selection of probiotic strains, their prebiotic counterparts, and delivery systems to avoid suppression of their synergistic or complementary effect on human health. Future directions should lead to the development of functional food products containing stable synbiotics tailored for different age groups or specifically designed to fulfill the needs of adjuvant therapy. MDPI 2021-06-04 /pmc/articles/PMC8230215/ /pubmed/34200108 http://dx.doi.org/10.3390/foods10061297 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kvakova, Monika Bertkova, Izabela Stofilova, Jana Savidge, Tor C. Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation |
title | Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation |
title_full | Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation |
title_fullStr | Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation |
title_full_unstemmed | Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation |
title_short | Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation |
title_sort | co-encapsulated synbiotics and immobilized probiotics in human health and gut microbiota modulation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230215/ https://www.ncbi.nlm.nih.gov/pubmed/34200108 http://dx.doi.org/10.3390/foods10061297 |
work_keys_str_mv | AT kvakovamonika coencapsulatedsynbioticsandimmobilizedprobioticsinhumanhealthandgutmicrobiotamodulation AT bertkovaizabela coencapsulatedsynbioticsandimmobilizedprobioticsinhumanhealthandgutmicrobiotamodulation AT stofilovajana coencapsulatedsynbioticsandimmobilizedprobioticsinhumanhealthandgutmicrobiotamodulation AT savidgetorc coencapsulatedsynbioticsandimmobilizedprobioticsinhumanhealthandgutmicrobiotamodulation |